Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 28, 2017; 23(44): 7818-7829
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7818
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7818
Figure 2 Validation of OncoScan copy number aberration data.
The CNAs of (A) MDM2, (B) KRAS, (C) MYC, and (D) RRM2 in early-stage HCC were validated by TaqMan copy number assay. Correlations between OncoScan CNAs and TaqMan PCR-determined CNAs were calculated via Pearson’s correlation r and P-value. The X-axis shows the CNA results from TaqMan PCR and the Y-axis shows that of the OncoScan data. CNA: Copy number aberration.
- Citation: Yu MC, Lee CW, Lee YS, Lian JH, Tsai CL, Liu YP, Wu CH, Tsai CN. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data. World J Gastroenterol 2017; 23(44): 7818-7829
- URL: https://www.wjgnet.com/1007-9327/full/v23/i44/7818.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i44.7818